Abstract:Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog--but not Oct4--is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes, but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.

Pluripotency Activity of Nanog Requires Biochemical Stabilization by Variant Histone Protein H2a.Z

H2A.Z facilitates access of active and repressive complexes to chromatin in embryonic stem cell self-renewal and differentiation.

Nanog safeguards pluripotency and mediates germline development

Pluripotential competence of cells associated with Nanog activity

USP21 Deubiquitylates Nanog to Regulate Protein Stability and Stem Cell Pluripotency

Control of ground-state pluripotency by allelic regulation of Nanog

Nanog and transcriptional networks in embryonic stem cell pluripotency

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

Nanog promotes transfer of pluripotency after cell fusion

Nanog Rna-Binding Proteins Ybx1 and Ilf3 Affect Pluripotency of Embryonic Stem Cells

Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells

O-GlcNAcase Regulates Pluripotency States of Human Embryonic Stem Cells

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

Concise Review: Pursuing Self-Renewal and Pluripotency with the Stem Cell Factor Nanog

Phosphorylation Stabilizes Nanog by Promoting Its Interaction with Pin1

Transcriptional Regulation of Nanog by OCT4 and SOX2

A Heterogeneous Expression Pattern for Nanog in Embryonic Stem Cells

Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells

The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells

Zfp281 functions as a transcriptional repressor for pluripotency of mouse embryonic stem cells.

A Protein Interaction Network for Pluripotency of Embryonic Stem Cells